XML 59 R24.htm IDEA: XBRL DOCUMENT v3.20.1
Share-based Payment Arrangements (Tables)
 3 Months Ended
Mar. 28, 2020
Amounts Recognized in Financial Statements with Respect to Plans Amounts recognized in the financial statements with respect to these Plans are as follows (in thousands):
                 
 
Thirteen Weeks Ended
 
 
March 28,
2020
 
  
March 30,
2019
 
Total cost of the Plans during the period
  $
631
    $
1,938
 
Amount of related income tax benefit recognized during the period
   
(873
 )    
(3,062
 )
                 
Net cost of the Plans during the period
  $
(242
 )   $
(1,124
 )
                 
 
Summary of Information Regarding Stock Options
The following table summarizes information regarding the Company’s outstanding stock options under the Plans:
                                 
 
Number of
Options
 
  
Weighted Average
Exercise Price
 
per
Share
 
  
Weighted Average
Remaining
Contractual
Term (years)
 
  
Aggregate Intrinsic
Value (000s)
 
Options outstanding at December 28, 2019
   
44,467
     $
51.24
      
     
 
Exercised
   
(15,767
 )   $
47.50
      
     
 
                                 
Options outstanding at March 28, 2020
   
28,700
     $
53.29
      
2.3
    $
1,128
  
                                 
Options exercisable at March 28, 2020
   
28,700
     $
53.29
      
2.3
    $
1,128
  
                                 
 
Restricted Stock Units (RSUs)  
Schedule of Information on Restricted Stock Units
The following table summarizes information regarding the Company’s outstanding restricted stock unit (“RSU”) awards with either a performance condition or a market condition under the Plans:
                 
 
Number of
RSUs
 
  
Weighted Average
Grant Date
Fair Value
 
Outstanding at December 28, 2019
   
198,875
    $
84.37
 
Granted
   
59,230
    $
102.70
  
Shares earned in excess of target
(1)
    
11,648
    $
77.00
 
Vested shares, including shares earned in excess of target
   
(70,247
 )   $
77.00
 
Forfeited
   
(10,237
 )   $
100.55
  
                 
Outstanding at March 28, 2020
   
189,269
    $
91.51
 
                 
 
 
 
(1)
Represents shares earned in excess of target under the February 2, 2017 RSU awards as actual results exceeded the target under the awards as a result of fiscal year 2019 results.
 
Non Vested Restricted Stock and Deferred Stock Units  
Schedule of Information on Non-Vested Restricted Stock and Deferred Stock Units
The following table summarizes information regarding the Company’s outstanding shares of
non-vested
restricted stock and Deferred Stock Units (defined below) under the Plans:
                 
 
Number of Shares
and Deferred Stock
Units
 
  
Weighted Average
Grant Date
Fair Value
 
Non-vested
at December 28, 2019
    
64,808
    $
98.24
 
Granted
   
20,736
    $
111.73
 
Vested
   
(19,878
 )   $
97.95
 
Forfeited
   
(2,351
 )   $
106.34
 
                 
Non-vested
at March 28, 2020
    
63,315
    $
102.45